These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8210924)

  • 1. Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
    Bacon P
    Rheumatol Int; 1993; 13(2 Suppl):S7-12. PubMed ID: 8210924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S19-24. PubMed ID: 8210920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee.
    Platt PN
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():54-62. PubMed ID: 2525984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy of etodolac SR (Lodine SR) and etodolac (Lodine) in patients with rheumatoid arthritis or osteoarthritis.
    Dreiser RL
    Rheumatol Int; 1993; 13(2 Suppl):S13-8. PubMed ID: 8210919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee.
    Khan FM; Williams PI
    Curr Med Res Opin; 1992; 13(1):1-12. PubMed ID: 1468239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of etodolac and diclofenac in osteoarthritis of the knee.
    Grisanti AM; Vaz AA; Samara AM
    Clin Ther; 1992; 14(6):791-800. PubMed ID: 1286486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Liang TH; Hsu PN
    Curr Med Res Opin; 2003; 19(4):336-41. PubMed ID: 12841927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee.
    Astorga Paulsen G; Baigun S; Galvao de Figueiredo J; Gomes de Freitas G
    Curr Med Res Opin; 1991; 12(6):401-12. PubMed ID: 1828415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study.
    Dore R; Ballard I; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):656-66. PubMed ID: 8565029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis.
    Freitas GG
    Curr Med Res Opin; 1990; 12(4):255-62. PubMed ID: 2150187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of two double-blind comparative studies with the sustained-release form of etodolac in rheumatoid arthritis.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S25-30. PubMed ID: 8210921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee.
    Karbowski A
    Curr Med Res Opin; 1991; 12(5):309-17. PubMed ID: 1825972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis.
    Chikanza IC; Clarke B; Hopkins R; MacFarlane DG; Bird H; Grahame R
    Br J Clin Pract; 1994; 48(2):67-9. PubMed ID: 8024992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ; Ballard IM; Constantine G; McDonald P
    Clin Ther; 1995; 17(4):602-12. PubMed ID: 8565024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clinical Effectiveness and Safety of Newer Nonsteroidal Anti-inflammatory Drugs in Patients of Osteoarthritis of Knee Joint: A Randomized, Prospective, Open-label Parallel-group Study.
    Garg Y; Singh J; Sohal HS; Gore R; Kumar A
    Indian J Pharmacol; 2017; 49(5):383-389. PubMed ID: 29515279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etodolac (Lodine) in the treatment of osteoarthritis: recent studies.
    Schnitzer TJ; Constantine G
    J Rheumatol Suppl; 1997 Feb; 47():23-31. PubMed ID: 9035017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.